Prophylactic HIV Drug Market
HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become t ... Read More
1 Introduction to Research & Analysis Reports 1.1 Extended Release Drug Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Extended Release Drug Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Extended Release Drug Overall Market Size 2.1 Global Extended Release Drug Market Size: 2021 VS 2028 2.2 Global Extended Release Drug Market Size, Prospects & Forecasts: 2017-2028 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Extended Release Drug Players in Global Market 3.2 Top Global Extended Release Drug Companies Ranked by Revenue 3.3 Global Extended Release Drug Revenue by Companies 3.4 Top 3 and Top 5 Extended Release Drug Companies in Global Market, by Revenue in 2021 3.5 Global Companies Extended Release Drug Product Type 3.6 Tier 1, Tier 2 and Tier 3 Extended Release Drug Players in Global Market 3.6.1 List of Global Tier 1 Extended Release Drug Companies 3.6.2 List of Global Tier 2 and Tier 3 Extended Release Drug Companies 4 Market Sights by Product 4.1 Overview 4.1.1 by Type - Global Extended Release Drug Market Size Markets, 2021 & 2028 4.1.2 Sustained Release Drug 4.1.3 Controlled Release Drug 4.2 By Type - Global Extended Release Drug Revenue & Forecasts 4.2.1 By Type - Global Extended Release Drug Revenue, 2017-2022 4.2.2 By Type - Global Extended Release Drug Revenue, 2023-2028 4.2.3 By Type - Global Extended Release Drug Revenue Market Share, 2017-2028 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Extended Release Drug Market Size, 2021 & 2028 5.1.2 Hospital Pharmacy 5.1.3 Retail Pharmacy 5.1.4 Online Pharmacy 5.2 By Application - Global Extended Release Drug Revenue & Forecasts 5.2.1 By Application - Global Extended Release Drug Revenue, 2017-2022 5.2.2 By Application - Global Extended Release Drug Revenue, 2023-2028 5.2.3 By Application - Global Extended Release Drug Revenue Market Share, 2017-2028 6 Sights by Region 6.1 By Region - Global Extended Release Drug Market Size, 2021 & 2028 6.2 By Region - Global Extended Release Drug Revenue & Forecasts 6.2.1 By Region - Global Extended Release Drug Revenue, 2017-2022 6.2.2 By Region - Global Extended Release Drug Revenue, 2023-2028 6.2.3 By Region - Global Extended Release Drug Revenue Market Share, 2017-2028 6.3 North America 6.3.1 By Country - North America Extended Release Drug Revenue, 2017-2028 6.3.2 US Extended Release Drug Market Size, 2017-2028 6.3.3 Canada Extended Release Drug Market Size, 2017-2028 6.3.4 Mexico Extended Release Drug Market Size, 2017-2028 6.4 Europe 6.4.1 By Country - Europe Extended Release Drug Revenue, 2017-2028 6.4.2 Germany Extended Release Drug Market Size, 2017-2028 6.4.3 France Extended Release Drug Market Size, 2017-2028 6.4.4 U.K. Extended Release Drug Market Size, 2017-2028 6.4.5 Italy Extended Release Drug Market Size, 2017-2028 6.4.6 Russia Extended Release Drug Market Size, 2017-2028 6.4.7 Nordic Countries Extended Release Drug Market Size, 2017-2028 6.4.8 Benelux Extended Release Drug Market Size, 2017-2028 6.5 Asia 6.5.1 By Region - Asia Extended Release Drug Revenue, 2017-2028 6.5.2 China Extended Release Drug Market Size, 2017-2028 6.5.3 Japan Extended Release Drug Market Size, 2017-2028 6.5.4 South Korea Extended Release Drug Market Size, 2017-2028 6.5.5 Southeast Asia Extended Release Drug Market Size, 2017-2028 6.5.6 India Extended Release Drug Market Size, 2017-2028 6.6 South America 6.6.1 By Country - South America Extended Release Drug Revenue, 2017-2028 6.6.2 Brazil Extended Release Drug Market Size, 2017-2028 6.6.3 Argentina Extended Release Drug Market Size, 2017-2028 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Extended Release Drug Revenue, 2017-2028 6.7.2 Turkey Extended Release Drug Market Size, 2017-2028 6.7.3 Israel Extended Release Drug Market Size, 2017-2028 6.7.4 Saudi Arabia Extended Release Drug Market Size, 2017-2028 6.7.5 UAE Extended Release Drug Market Size, 2017-2028 7 Players Profiles 7.1 Pfizer 7.1.1 Pfizer Corporate Summary 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Extended Release Drug Major Product Offerings 7.1.4 Pfizer Extended Release Drug Revenue in Global Market (2017-2022) 7.1.5 Pfizer Key News 7.2 Mallinckrodt 7.2.1 Mallinckrodt Corporate Summary 7.2.2 Mallinckrodt Business Overview 7.2.3 Mallinckrodt Extended Release Drug Major Product Offerings 7.2.4 Mallinckrodt Extended Release Drug Revenue in Global Market (2017-2022) 7.2.5 Mallinckrodt Key News 7.3 Teva 7.3.1 Teva Corporate Summary 7.3.2 Teva Business Overview 7.3.3 Teva Extended Release Drug Major Product Offerings 7.3.4 Teva Extended Release Drug Revenue in Global Market (2017-2022) 7.3.5 Teva Key News 7.4 Johnson & Johnson 7.4.1 Johnson & Johnson Corporate Summary 7.4.2 Johnson & Johnson Business Overview 7.4.3 Johnson & Johnson Extended Release Drug Major Product Offerings 7.4.4 Johnson & Johnson Extended Release Drug Revenue in Global Market (2017-2022) 7.4.5 Johnson & Johnson Key News 7.5 Endo Pharmaceuticals 7.5.1 Endo Pharmaceuticals Corporate Summary 7.5.2 Endo Pharmaceuticals Business Overview 7.5.3 Endo Pharmaceuticals Extended Release Drug Major Product Offerings 7.5.4 Endo Pharmaceuticals Extended Release Drug Revenue in Global Market (2017-2022) 7.5.5 Endo Pharmaceuticals Key News 7.6 Purdue Pharma 7.6.1 Purdue Pharma Corporate Summary 7.6.2 Purdue Pharma Business Overview 7.6.3 Purdue Pharma Extended Release Drug Major Product Offerings 7.6.4 Purdue Pharma Extended Release Drug Revenue in Global Market (2017-2022) 7.6.5 Purdue Pharma Key News 7.7 Mylan 7.7.1 Mylan Corporate Summary 7.7.2 Mylan Business Overview 7.7.3 Mylan Extended Release Drug Major Product Offerings 7.7.4 Mylan Extended Release Drug Revenue in Global Market (2017-2022) 7.7.5 Mylan Key News 7.8 Hisamitsu Pharmaceutical 7.8.1 Hisamitsu Pharmaceutical Corporate Summary 7.8.2 Hisamitsu Pharmaceutical Business Overview 7.8.3 Hisamitsu Pharmaceutical Extended Release Drug Major Product Offerings 7.8.4 Hisamitsu Pharmaceutical Extended Release Drug Revenue in Global Market (2017-2022) 7.8.5 Hisamitsu Pharmaceutical Key News 7.9 Sun Pharmaceutical Industries 7.9.1 Sun Pharmaceutical Industries Corporate Summary 7.9.2 Sun Pharmaceutical Industries Business Overview 7.9.3 Sun Pharmaceutical Industries Extended Release Drug Major Product Offerings 7.9.4 Sun Pharmaceutical Industries Extended Release Drug Revenue in Global Market (2017-2022) 7.9.5 Sun Pharmaceutical Industries Key News 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer
List of Tables Table 1. Extended Release Drug Market Opportunities & Trends in Global Market Table 2. Extended Release Drug Market Drivers in Global Market Table 3. Extended Release Drug Market Restraints in Global Market Table 4. Key Players of Extended Release Drug in Global Market Table 5. Top Extended Release Drug Players in Global Market, Ranking by Revenue (2021) Table 6. Global Extended Release Drug Revenue by Companies, (US$, Mn), 2017-2022 Table 7. Global Extended Release Drug Revenue Share by Companies, 2017-2022 Table 8. Global Companies Extended Release Drug Product Type Table 9. List of Global Tier 1 Extended Release Drug Companies, Revenue (US$, Mn) in 2021 and Market Share Table 10. List of Global Tier 2 and Tier 3 Extended Release Drug Companies, Revenue (US$, Mn) in 2021 and Market Share Table 11. By Type – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028 Table 12. By Type - Extended Release Drug Revenue in Global (US$, Mn), 2017-2022 Table 13. By Type - Extended Release Drug Revenue in Global (US$, Mn), 2023-2028 Table 14. By Application – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028 Table 15. By Application - Extended Release Drug Revenue in Global (US$, Mn), 2017-2022 Table 16. By Application - Extended Release Drug Revenue in Global (US$, Mn), 2023-2028 Table 17. By Region – Global Extended Release Drug Revenue, (US$, Mn), 2021 & 2028 Table 18. By Region - Global Extended Release Drug Revenue (US$, Mn), 2017-2022 Table 19. By Region - Global Extended Release Drug Revenue (US$, Mn), 2023-2028 Table 20. By Country - North America Extended Release Drug Revenue, (US$, Mn), 2017-2022 Table 21. By Country - North America Extended Release Drug Revenue, (US$, Mn), 2023-2028 Table 22. By Country - Europe Extended Release Drug Revenue, (US$, Mn), 2017-2022 Table 23. By Country - Europe Extended Release Drug Revenue, (US$, Mn), 2023-2028 Table 24. By Region - Asia Extended Release Drug Revenue, (US$, Mn), 2017-2022 Table 25. By Region - Asia Extended Release Drug Revenue, (US$, Mn), 2023-2028 Table 26. By Country - South America Extended Release Drug Revenue, (US$, Mn), 2017-2022 Table 27. By Country - South America Extended Release Drug Revenue, (US$, Mn), 2023-2028 Table 28. By Country - Middle East & Africa Extended Release Drug Revenue, (US$, Mn), 2017-2022 Table 29. By Country - Middle East & Africa Extended Release Drug Revenue, (US$, Mn), 2023-2028 Table 30. Pfizer Corporate Summary Table 31. Pfizer Extended Release Drug Product Offerings Table 32. Pfizer Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 33. Mallinckrodt Corporate Summary Table 34. Mallinckrodt Extended Release Drug Product Offerings Table 35. Mallinckrodt Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 36. Teva Corporate Summary Table 37. Teva Extended Release Drug Product Offerings Table 38. Teva Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 39. Johnson & Johnson Corporate Summary Table 40. Johnson & Johnson Extended Release Drug Product Offerings Table 41. Johnson & Johnson Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 42. Endo Pharmaceuticals Corporate Summary Table 43. Endo Pharmaceuticals Extended Release Drug Product Offerings Table 44. Endo Pharmaceuticals Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 45. Purdue Pharma Corporate Summary Table 46. Purdue Pharma Extended Release Drug Product Offerings Table 47. Purdue Pharma Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 48. Mylan Corporate Summary Table 49. Mylan Extended Release Drug Product Offerings Table 50. Mylan Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 51. Hisamitsu Pharmaceutical Corporate Summary Table 52. Hisamitsu Pharmaceutical Extended Release Drug Product Offerings Table 53. Hisamitsu Pharmaceutical Extended Release Drug Revenue (US$, Mn), (2017-2022) Table 54. Sun Pharmaceutical Industries Corporate Summary Table 55. Sun Pharmaceutical Industries Extended Release Drug Product Offerings Table 56. Sun Pharmaceutical Industries Extended Release Drug Revenue (US$, Mn), (2017-2022) List of Figures Figure 1. Extended Release Drug Segment by Type in 2021 Figure 2. Extended Release Drug Segment by Application in 2021 Figure 3. Global Extended Release Drug Market Overview: 2021 Figure 4. Key Caveats Figure 5. Global Extended Release Drug Market Size: 2021 VS 2028 (US$, Mn) Figure 6. Global Extended Release Drug Revenue, 2017-2028 (US$, Mn) Figure 7. The Top 3 and 5 Players Market Share by Extended Release Drug Revenue in 2021 Figure 8. By Type - Global Extended Release Drug Revenue Market Share, 2017-2028 Figure 9. By Application - Global Extended Release Drug Revenue Market Share, 2017-2028 Figure 10. By Region - Global Extended Release Drug Revenue Market Share, 2017-2028 Figure 11. By Country - North America Extended Release Drug Revenue Market Share, 2017-2028 Figure 12. US Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 13. Canada Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 14. Mexico Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 15. By Country - Europe Extended Release Drug Revenue Market Share, 2017-2028 Figure 16. Germany Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 17. France Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 18. U.K. Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 19. Italy Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 20. Russia Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 21. Nordic Countries Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 22. Benelux Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 23. By Region - Asia Extended Release Drug Revenue Market Share, 2017-2028 Figure 24. China Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 25. Japan Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 26. South Korea Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 27. Southeast Asia Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 28. India Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 29. By Country - South America Extended Release Drug Revenue Market Share, 2017-2028 Figure 30. Brazil Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 31. Argentina Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 32. By Country - Middle East & Africa Extended Release Drug Revenue Market Share, 2017-2028 Figure 33. Turkey Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 34. Israel Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 35. Saudi Arabia Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 36. UAE Extended Release Drug Revenue, (US$, Mn), 2017-2028 Figure 37. Pfizer Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 38. Mallinckrodt Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 39. Teva Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 40. Johnson & Johnson Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 41. Endo Pharmaceuticals Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 42. Purdue Pharma Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 43. Mylan Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 44. Hisamitsu Pharmaceutical Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022) Figure 45. Sun Pharmaceutical Industries Extended Release Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
65
HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become t ... Read More
Cetanol is considered as a long chain compound falls under the category of organic ... Read More
Industrial Ceramics refers to an umbrella term which is related to ceramic material ... Read More
Tallow amines represents the wide range of non-ionic surfactants derived from animal fats i.e. ta ... Read More